Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Non-Current Deferred Tax Liability (2020 - 2025)

Oncology Institute's Non-Current Deferred Tax Liability history spans 6 years, with the latest figure at $32000.0 for Q1 2025.

  • For Q1 2025, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $32000.0; the TTM value through Mar 2025 reached $32000.0, changed 0.0%, while the annual FY2024 figure was $32000.0, 99.69% down from the prior year.
  • Non-Current Deferred Tax Liability reached $32000.0 in Q1 2025 per TOI's latest filing, roughly flat from $32000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $10.2 million in Q4 2023 to a low of $32000.0 in Q1 2024.
  • Average Non-Current Deferred Tax Liability over 5 years is $1.6 million, with a median of $120000.0 recorded in 2023.
  • Peak YoY movement for Non-Current Deferred Tax Liability: soared 327.84% in 2022, then tumbled 99.69% in 2024.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.0 million in 2021, then surged by 327.84% to $8.7 million in 2022, then increased by 17.38% to $10.2 million in 2023, then crashed by 99.69% to $32000.0 in 2024, then changed by 0.0% to $32000.0 in 2025.
  • Per Business Quant, the three most recent readings for TOI's Non-Current Deferred Tax Liability are $32000.0 (Q1 2025), $32000.0 (Q4 2024), and $32000.0 (Q3 2024).